Literature DB >> 22112806

New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.

Heike Biebermann1, Franziska Winkler, Daniela Handke, Anke Teichmann, Burkhard Gerling, Fergus Cameron, Jenny Eichhorst, Annette Grüters, Burkhard Wiesner, Peter Kühnen, Heiko Krude, Gunnar Kleinau.   

Abstract

CONTEXT: In this paper we report two new TSH receptor (TSHR) mutations. One mutation (Pro639(6.50)Leu) was identified in two siblings with congenital hypothyroidism, and a second mutation (Cys636(6.47)Arg) was found in a patient suffering from nonautoimmune hyperthyroidism. Both mutations are located in transmembrane helix (TMH) 6 at the conserved Cys(6.47)-Trp(Met)(6.48)-Leu(Ala)(6.49)-Pro(6.50) motif of family A G protein-coupled receptors (GPCR).
OBJECTIVE: To study the pathogenic mechanisms, we tested patients' mutations and further side chain variations regarding their effects on TSHR signaling.
RESULTS: Substitution Pro639Leu fully inactivates the promiscuous TSHR for cAMP (Gs) and IP (Gq) signaling. In contrast, Cys636Arg leads to constitutive activation of Gs. Organization of TSHR in oligomers was not modified by mutations at position 636. Interestingly, it is known from crystal structures of GPCR that Pro(6.50) is located at a TMH6 kink-distortion, which is a pivot during activation-related helical movements. However, the cell surface expressions of all mutants at position 639 were comparable to wild type, indicating a helical conformation like wild type.
CONCLUSION: Until now, only naturally occurring constitutively activating mutations in TSHR TMH6 have been reported, but here we present the first pathogenic inactivating mutation (Pro639Leu). Our data are indicative of differentiated regulation of Gs and Gq signaling at particular TMH6 positions, but without any effects on TSHR oligomer constellation. Details of signaling modulation by each mutant at positions 636(6.47) and 639(6.50) help us to understand high conservation of these amino acids in family A GPCR. Described molecular (pathogenic) mechanisms are likely not unique for TSHR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22112806     DOI: 10.1210/jc.2011-2106

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Minireview: Insights Into the Structural and Molecular Consequences of the TSH-β Mutation C105Vfs114X.

Authors:  Gunnar Kleinau; Laura Kalveram; Josef Köhrle; Mariusz Szkudlinski; Lutz Schomburg; Heike Biebermann; Annette Grüters-Kieslich
Journal:  Mol Endocrinol       Date:  2016-07-07

2.  Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12.

Authors:  Y Zhang; J Ye; L Hu; S Zhang; S H Zhang; Y Li; S P Kunapuli; Z Ding
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

3.  The W520X mutation in the TSHR gene brings on subclinical hypothyroidism through an haploinsufficiency mechanism.

Authors:  S Moia; M Godi; G E Walker; M Roccio; P Agretti; M Tonacchera; R Berardi; S Bellone; F Prodam; M Giordano; G Bona
Journal:  J Endocrinol Invest       Date:  2013-04-08       Impact factor: 4.256

Review 4.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

5.  A new family with an activating mutation (G431S) in the TSH receptor gene: a phenotype discussion and review of the literature.

Authors:  Cæcilie C Larsen; Lefkothea P Karaviti; Victor Seghers; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Int J Pediatr Endocrinol       Date:  2014-11-17

6.  Structure and activation of the TSH receptor transmembrane domain.

Authors:  Ricardo Núñez Miguel; Jane Sanders; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2016-12-05

Review 7.  Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

Authors:  Gunnar Kleinau; Catherine L Worth; Annika Kreuchwig; Heike Biebermann; Patrick Marcinkowski; Patrick Scheerer; Gerd Krause
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

8.  Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders.

Authors:  Grazia Rutigliano; Julia Bräunig; Claudia Del Grande; Vittoria Carnicelli; Isabella Masci; Sergio Merlino; Gunnar Kleinau; Luca Tessieri; Simone Pardossi; Sarah Paisdzior; Liliana Dell'Osso; Heike Biebermann; Riccardo Zucchi
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

9.  G-protein coupled receptor 83 (GPR83) signaling determined by constitutive and zinc(II)-induced activity.

Authors:  Anne Müller; Gunnar Kleinau; Carolin L Piechowski; Timo D Müller; Brian Finan; Juliane Pratzka; Annette Grüters; Heiko Krude; Matthias Tschöp; Heike Biebermann
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  The role of Cysteine 6.47 in class A GPCRs.

Authors:  Mireia Olivella; Gianluigi Caltabiano; Arnau Cordomí
Journal:  BMC Struct Biol       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.